Medicare Enrolled
Dr. Philip Veatch, MD
Internal Medicine · Albemarle, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Veatch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Veatch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Veatch
Dr. Philip Veatch is an internal medicine specialist in Albemarle, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Veatch performed 4,651 Medicare services across 1,880 unique beneficiaries.
Between the years covered by Open Payments, Dr. Veatch received a total of $9,909 from 44 pharmaceutical and/or device companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Veatch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in NC
$9,909 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,651
Medicare services
Top 8% in NC for internal medicine
1,880
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~233 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
770 | $80 | $144 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
428 | $33 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
288 | $124 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $56 | $98 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
182 | $15 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
177 | $9 | $27 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
169 | $4 | $25 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 156 | $20 | $25 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
153 | $26 | $27 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
95 | $0 | $5 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
92 | $3 | $12 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
79 | $121 | $187 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
61 | $31 | $48 |
| Annual depression screening | 44 | $0 | $0 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
31 | $10 | $55 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
28 | $4 | $17 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
24 | $37 | $52 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
22 | $16 | $30 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
16 | $9 | $15 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
15 | $11 | $80 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
14 | $35 | $36 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $37 | $65 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $137 | $177 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
12 | $159 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,909
Total received (2018-2024)
Avg $1,416/year across 7 years
Top 10% in NC for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
663
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,857 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,837
2023
$2,044
2022
$1,377
2021
$1,338
2020
$470
2019
$1,583
2018
$1,261
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$265
PFIZER INC.
$196
Novo Nordisk Inc
$184
ABBVIE INC.
$146
Lilly USA, LLC
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$99
Amgen Inc.
$97
Novartis Pharmaceuticals Corporation
$82
Exact Sciences Corporation
$79
Astellas Pharma US Inc
$70
Sumitomo Pharma America, Inc.
$68
GlaxoSmithKline, LLC.
$66
Phathom Pharmaceuticals, Inc.
$57
Mylan Specialty L.P.
$56
E.R. Squibb & Sons, L.L.C.
$53
Esperion Therapeutics, Inc.
$51
Xeris Pharmaceuticals, Inc.
$39
SHIELD THERAPEUTICS INC
$35
Boston Scientific Corporation
$24
Abbott Laboratories
$24
IDORSIA PHARMACEUTICALS US INC
$17
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 35.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,460
PFIZER INC.
$862
AstraZeneca Pharmaceuticals LP
$826
Lilly USA, LLC
$711
Amgen Inc.
$581
Boehringer Ingelheim Pharmaceuticals, Inc.
$562
Astellas Pharma US Inc
$448
Novartis Pharmaceuticals Corporation
$388
SANOFI-AVENTIS U.S. LLC
$364
ABBVIE INC.
$349
AbbVie Inc.
$299
GlaxoSmithKline, LLC.
$282
Xeris Pharmaceuticals, Inc.
$209
Kowa Pharmaceuticals America, Inc.
$208
Janssen Pharmaceuticals, Inc
$199
E.R. Squibb & Sons, L.L.C.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$168
Exact Sciences Corporation
$153
Esperion Therapeutics, Inc.
$145
Sumitomo Pharma America, Inc.
$142
Amarin Pharma Inc.
$142
Mylan Specialty L.P.
$138
Bayer HealthCare Pharmaceuticals Inc.
$115
Allergan Inc.
$98
Merck Sharp & Dohme Corporation
$98
Biohaven Pharmaceutical Holding Company Ltd.
$91
Phathom Pharmaceuticals, Inc.
$81
Bayer Healthcare Pharmaceuticals Inc.
$72
Bausch Health US, LLC
$63
IDORSIA PHARMACEUTICALS US INC
$61
Radius Health, Inc.
$59
Medtronic, Inc.
$57
EISAI INC.
$41
Otsuka America Pharmaceutical, Inc.
$41
SHIELD THERAPEUTICS INC
$35
Merck Sharp & Dohme LLC
$32
Eisai Inc.
$25
Boston Scientific Corporation
$24
Abbott Laboratories
$24
Intuity Medical Inc
$19
Biohaven Pharmaceuticals, Inc.
$18
Ironwood Pharmaceuticals, Inc
$16
Currax Pharmaceuticals LLC
$15
Shield Therapeutics Inc
$14
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AIRSUPRA · APLENZIN · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BREZTRI · BYDUREON · BYSTOLIC · Belviq · CHANTIX · COMIRNATY · CONTRAVE · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 3 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Linzess · Livalo · MINIMED 780G · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 20 · Perforomist · Pogo Automatic Blood Glucose Monitoring System · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Seglentis · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIIBRYD · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in NC.
Geographic Context
Internal medicine physicians within 10 mi
123
Per 100K population
193.5
County median income
$61,631
Nearest hospital
STANLY REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Veatch is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NC), with low-engagement industry engagement in the top 10% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Veatch experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Veatch performed 1,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Veatch receive payments from pharmaceutical companies?
Yes. Dr. Veatch received a total of $9,909 from 44 companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Veatch's costs compare to other internal medicine physicians in Albemarle?
Dr. Veatch's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Veatch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Albemarle
Browse internal medicine physicians in Albemarle ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NC
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NC
Which NC internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology